As a leadership team, we are focused on high performance to benefit patients, clinicians, and shareholders.
MICHAEL F. MAHONEY
President and Chief Executive Officer
Senior Vice President and President Interventional Cardiology
Executive Vice President and President, Asia-Pac, Middle East and Africa (AMEA)
DANIEL J. BRENNAN
Executive Vice President and Chief Financial Officer
Senior Vice President Human Resources
KEITH D. DAWKINS
Executive Vice President and Global Chief Medical Officer
JOSEPH M. FITZGERALD
Executive Vice President and President, Rhythm Management
Executive Vice President, Operations
Senior Vice President and President, Peripheral Interventions
Senior Vice President and President, Neuromodulation
MICHAEL P. PHALEN
Executive Vice President and President, MedSurg
DAVID A. PIERCE
Senior Vice President and President, Endoscopy
Senior Vice President and President, Urology and Pelvic Health
TIMOTHY A. PRATT
Executive Vice President, Chief Administrative Officer, General Counsel and Secretary
Senior Vice President, Manufacturing and Supply Chain
Michael Mahoney is President and Chief Executive Officer of Boston Scientific Corporation and a member of the company’s board of directors. Mahoney oversees global development, marketing and sales of the company’s broad medical solutions portfolio. He assumed this role in November 2012, after serving one year as president of Boston Scientific, leading the Cardiac Rhythm Management (CRM) and Endoscopy (GI and Pulmonary) business divisions. Mahoney joined the company in October 2011, with a 24-year track record of building market-leading medical device, capital equipment and healthcare IT businesses.
Prior to Boston Scientific, Mahoney served as Worldwide Chairman of Johnson & Johnson’s Medical Devices and Diagnostics (MD&D) division, overseeing seven franchises and 50,000 employees. He previously served as Worldwide Group Chairman of Johnson & Johnson’s DePuy orthopedics and neuro-sciences business, where he drove growth through product innovation, acquisitions and market expansion into China and India.
Mahoney was President and Chief Executive Officer of Global Healthcare Exchange (GHX), a leading supply chain solutions company. He built GHX through organic development, seven strategic acquisitions and expanding into Canada and Europe. For the first 12 years of Mahoney’s career, he advanced through a series of leadership roles at General Electric Medical Systems, reaching the position of General Manager of the company’s Healthcare Information Technology business.
Mahoney serves on AdvaMed's board of directors and is a member of the American Heart Association CEO Roundtable. He earned a B.B.A. in Finance from the University of Iowa and his M.B.A. from Wake Forest University. Mike is married and has three children.
Kevin Ballinger is Senior Vice President and Global President, Interventional Cardiology for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for developing and bringing to market innovative solutions that diagnose and treat coronary artery disease and cardiac valve disorders.
Ballinger has more than 17 years of interventional cardiology experience. Prior to his current role, he held a variety of engineering and general management positions within Boston Scientific’s Interventional Cardiology business unit, including overseeing the development of the company’s first drug-eluting stents.
Ballinger earned a B.S. in Mechanical Engineering from Michigan Tech University and an MBA from the University of Minnesota.
Supratim Bose is Executive Vice President and President, Asia-Pac, Middle East and Africa (AMEA)for Boston Scientific and a member of its Executive Committee. In this role, Supratim oversees the Company’s business and growth opportunities across Asia-Pacific, the world’s fastest growing region, plus the Middle East and Africa.
Before joining Boston Scientific in January 2012, Supratim was Founder and Chief Executive Officer of Singapore-based Bose Consulting Group, which specialized in strategic management consulting services for the healthcare industry. Previously, he worked for nearly 30 years at Johnson & Johnson, where he concluded his tenure as Company Group Chairman of its Medical Devices and Diagnostics (MD&D) business. In this role, he managed Johnson & Johnson’s MD&D companies throughout Asia-Pacific, including Japan, having pioneered its entry in all emerging markets in Asia, including China, India, and Vietnam. During his tenure, he also created the company’s research and development capability in the region and led the development and growth of local talent. Under Supratim’s leadership, the organization partnered closely with key external stakeholders to shape the healthcare environment, and was recognized by external agencies as one of the top companies to work for in Asia-Pacific.
Supratim joined Johnson & Johnson Ltd. India in 1981, and held a variety of management positions of increasing responsibility leading up to his appointment as Company Group Chairman of MD&D. He has extensive and proven experience in building markets in this region. Prior to J&J, he served at one of the top growing pharmaceutical start-ups in India.
Supratim earned a B.S. in Chemistry/Physics, a M.S. in Biophysics and a Master in Management Studies from the Jamnalal Bajaj Institute of Management Studies at the University of Bombay. He served as a a member of the Board of Directors at Quattro Vascular Pte Ltd and Trireme Medical, and member of the Advisory Board at Singapore Management University’s Lee Kong Chian School of Business. He continues to teach at the Nanyang Business School, Singapore, as a visiting faculty member.
Daniel Brennan is Executive Vice President and Chief Financial Officer for Boston Scientific Corporation and a member of its Executive Committee. In this role, he is responsible for several Company functions, including Global Controllership, Corporate Finance, Treasury, Corporate Tax, Corporate Analysis and Control, and Corporate New Business Development.
Previously, he served as Senior Vice President and Corporate Controller. In this role, Brennan was responsible for the Global Controllership organization, including the Company’s accounting and financial planning processes.
Brennan joined Boston Scientific in 1996 and has served in a number of financial roles of increasing responsibility, including Assistant Corporate Controller; Vice President-Worldwide Financial & Strategic Planning; Vice President-Investor Relations, Vice President-International Finance and Vice President-Finance & Information Technology for the company’s Cardiovascular Division.
Prior to joining Boston Scientific, Brennan held several finance positions at Millipore Corporation and Standex Corporation.
Brennan is a Certified Public Accountant and earned his B.S. in Finance and Investments and his M.B.A. from Babson College.
Wendy Carruthers is Senior Vice President of Human Resources for Boston Scientific Corporation and a member of its Executive Committee. In this role, she provides strategic leadership to the global HR function, including HR operations, total rewards, talent management, diversity and inclusion, and community relations.
Prior to her current role, Carruthers served as Vice President of Global Talent Management for Boston Scientific, responsible for all aspects of global talent management including the design, development and implementation of global processes and systems to enable managers to identify, attract and develop people.
Carruthers has been with Boston Scientific since 2004 and was previously Vice President of Human Resources for the company’s Europe, Middle East and Africa (EMEA) region, based in Paris.
Prior to joining Boston Scientific, Carruthers was Vice President of Human Resources, Europe for global telecommunications company Cable & Wireless. She also previously worked in human resources for Diageo, a premium drinks business, and Tesco, a U.K. retailer.
A native of Great Britain, Carruthers has lived and worked in the U.K., France, Italy, Australia and the United States. She holds a B.A. First Class Honors Degree in Modern Languages and is a Fellow of the Chartered Institute of Personnel and Development. She is also on the Board of the Boston Scientific Foundation and a member of the Board of Advisors of the Greater Boston Food Bank.
Keith Dawkins, M.D., is Executive Vice President and Global Chief Medical Officer for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for enhancing the Company’s global Clinical programs and strategies.
Prior to his current role, which he assumed in January 2012, Dr. Dawkins was Chief Medical Officer of Boston Scientific’s Cardiology, Rhythm and Vascular Group. He joined Boston Scientific in 2008 as Senior Vice President and Associate Chief Medical Officer for the Company’s Cardiovascular (CV) business. While in this role, he led Boston Scientific’s Clinical Integration Project, which brought together its former CV and Cardiac Rhythm Management Clinical organizations under the Company’s CRV Group.
Prior to joining Boston Scientific, Dr. Dawkins was a practicing interventional cardiologist for more than 20 years in England. He has earned a series of clinical, research and academic distinctions, including a Post-Doctoral Research Fellowship at Stanford University as a Fulbright Scholar. Dr. Dawkins served as President of the British Cardiovascular Intervention Society, and held numerous appointments on hospital, regional and national committees, including the National Institute for Health and Clinical Excellence (NICE). He has been an author on more than 450 academic publications and presentations on a variety of cardiac topics.
Dr. Dawkins earned a First-Class Honours degree in Pathology at London University and Guys Hospital. He trained in cardiology at Oxford and at the Brompton & St. George’s Hospital in London.
Joe Fitzgerald is Executive Vice President and President, Rhythm Management for Boston Scientific and a member of its Executive Committee.
Prior to his current role, Fitzgerald was President of Boston Scientific's Endovascular Unit, which included the Company's Peripheral Interventions, Electrophysiology, Neurovascular and IVUS businesses. Previously, he held a number of senior leadership positions at Boston Scientific, including President of our Electrophysiology business and Vice President of Global Marketing and U.S. Sales for the Company's Neurovascular business.
Edward Mackey is Executive Vice President, Operations for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for Global Manufacturing and Supply Chain, Quality and Regulatory, Information Services, Global Business Services, Global Business Excellence, Corporate Research and Development and Corporate Strategy and Marketing.
Ed is a seasoned executive with a track record of delivering strong results, leading large teams and developing innovative strategies. Prior to joining Boston Scientific in 2015, Ed was Worldwide President of DePuy Synthes Power Tools, a division of Johnson & Johnson, after having served as Vice President of Integration for Johnson & Johnson’s acquisition of Synthes.
Early in his career, Ed held management positions in Operations, Quality and Product Development at Raytheon’s Missile Systems division. In 1995, he moved to Johnson & Johnson Orthopaedics as a plant manager and progressed through a series of manufacturing and supply chain leadership roles, becoming Worldwide Vice President of Supply Chain and Manufacturing for DePuy in 2007.
Mr. Mackey holds a Bachelor of Science degree in Mechanical Engineering from Worcester Polytechnic Institute and an MBA from the University of Massachusetts.
Jeff Mirviss is Senior Vice President and President, Peripheral Interventions for Boston Scientific and a member of its Executive Committee. In that capacity he is responsible for developing and bringing to market innovative solutions for treating patients with high blood pressure, vascular system blockages and cancer.
Mirviss has more than 23 years of experience in medical device and pharmaceutical general management, marketing and sales. He has held positions of increasing responsibility since 1997 at Boston Scientific.
In addition to his roles at Boston Scientific, Mirviss has worked for companies ranging in size from a pre-revenue venture-backed medical device startup to Dow 30 companies.
A resident of Plymouth, Minn., Mirviss holds a Bachelor’s degree from the University of Minnesota and an MBA from the University of St. Thomas.
Maulik Nanavaty is Senior Vice President and President, Neuromodulation Division for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for the innovation leader in less-invasive microelectronic implantable technologies used to treat chronic neuropathic pain.
Prior to his current role, Nanavaty was President, Representative Director of Boston Scientific Japan. Previously, he was Vice President and General Manager of the Company's Interventional Cardiology business in Japan. During his tenure, Nanavaty managed the successful expansion of Cardiology business in that country. He joined Boston Scientific in 2005 as Vice President for Corporate Strategy for Japan, where he led business transformation and increased operational efficiency.
Prior to joining Boston Scientific, Nanavaty spent 16 years working in various executive positions at Baxter International, Inc., and Baxter Japan.
Nanavaty earned a Ph.D. in Pharmaceutical Sciences from the University of Illinois and a M.B.A. from the University of Chicago.
Nanavaty is a member of the Board of Directors for the California Health Institute (CHI). CHI is an independent 501(c)(6) organization devoted to researching and advocating policy to forward the interests of California's biomedical community.
Michael Phalen is Executive Vice President and President, Medical Surgery (MedSurg) for Boston Scientific and a member of its Executive Committee. In this role, he plans and executes Boston Scientific’s growth strategies for the Company’s Endoscopy, Urology/Women’s Health and Neuromodulation businesses. Phalen also oversees Boston Scientific operations in Canada and Latin America.
Prior to assuming his current position in January 2012, Phalen was President of Boston Scientific International. He was responsible for planning and executing Boston Scientific’s international growth strategy.
Phalen joined Boston Scientific in 1988 and held various management positions of increasing responsibilities including Territory Manager, Product Manager, Regional Sales Manager, Group Product Manager, Director of Marketing, Vice President of Global Marketing and Senior Vice President and President of the company’s Endoscopy division.
Before joining Boston Scientific, Phalen held management positions with MD Technology, Kendall Healthcare and Pennwalt Pharmaceuticals. He earned a B.S. in General Science from Villanova University and an M.B.A. from Fairleigh Dickinson University.
Dave Pierce is Senior Vice President and President, Endoscopy Division for Boston Scientific and a member of its Executive Committee. In this role, he develops and executes strategies for the Endoscopy business.
Prior to his current role, he was Endoscopy Vice President of Global Marketing, managing product marketing, communications and programs, market development, new business development and customer education. Pierce joined the Company in 1991 as a Territory Manager before assuming various management-level positions of increasing responsibility.
Before joining Boston Scientific, Pierce worked as a Senior Sales Representative for Airborne Express and served as a Captain in the United States Army.
Pierce earned a B.S. in Business Administration from Norwich University and a M.B.A. from Boston University.
Karen Prange is Senior Vice President and President, Urology and Pelvic Health for Boston Scientific and a member of its Executive Committee. In this role, she is responsible for developing and bringing to market innovative solutions for the treatment of various urological and gynecological disorders.
Prior to her current role, Ms. Prange spent 17 years with Johnson & Johnson in various medical device businesses and has been recognized as a results-driven leader with a significant track record in delivering multiple cycles of business results via strategic change and re-alignment, sales growth, market development, portfolio strategy and global product commercialization.
The recipient of a BS in Business Administration with honors from the University of Florida, Prange has also completed executive education coursework at UCLA Anderson School of Business and Smith College.
Tim Pratt is Executive Vice President, Chief Administrative Officer, General Counsel and Secretary for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for worldwide management of Boston Scientific’s Legal functions, Global Compliance, Government Affairs, Aviation, and Global Security.
Mr. Pratt served as President and Chairman of the Federation of Defense & Corporate Counsel ("FDCC"). He also serves as a Director on the Boards of Lawyers for Civil Justice ("LCJ"), DRI - The Voice of the Defense Bar, and the New England Legal Foundation ("NELF"). Mr. Pratt is a past member of the Board of Directors for the Advanced Medical Technology Association ("AdvaMed") and also served on their Executive Committee.
Mr. Pratt earned his Bachelor of Arts degree at Tarkio College and graduated Order of the Coif from Drake University Law School, where he served as editor-in-chief of the Drake Law Review. Prior to joining Boston Scientific in 2008, Mr. Pratt was a partner and trial attorney with the law firm of Shook, Hardy & Bacon. While there, he was named a Leading National Products Liability Lawyer by Chambers USA, one of the Top 500 Litigators in America by Lawdragon, and one of the Best Lawyers in America. In October of 2013, he was recognized by The Legal 500 and named to the "Corporate Counsel 100" list, which identifies the top most powerful corporate legal advisers in the United States.
Brad Sorenson is Senior Vice President, Manufacturing and Supply Chain for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for the global manufacturing and distribution of Boston Scientific’s products.
Sorenson has more than 16 years of medical device manufacturing experience. Prior to his current role, he held a variety of Operations positions at Boston Scientific, supporting the Cardiac Rhythm Management, Neuromodulation, Interventional Cardiology, Peripheral Interventions and Structural Heart businesses. Before joining Boston Scientific, he was President and COO of QRS Diagnostic and held manufacturing management positions at Federal Cartridge.
Sorenson earned a B.A. in Economics from Gustavus Adolphus College in St. Peter, MN and an MBA from the University of Minnesota.
Eric Thépaut is Senior Vice President and President, Europe for Boston Scientific and a member of its Executive Committee. Based at the regional headquarters in Paris, he is responsible for Boston Scientific’s businesses in Europe.
Prior to his current role, Thépaut was Vice President Interventional Cardiology & Structural Heart, Europe, since 2012. He joined Boston Scientific Europe, in 1996, as a business finance manager and earned roles of increasing responsibility in Marketing and Finance, becoming Vice President, Finance, Europe, in 2002. Eric was next promoted to General Manager and Vice President, France, and then the France Group, comprised of France, Benelux and Middle East North Africa. Before coming to Boston Scientific, Eric held management positions in treasury operations and auditing at Nestlé and financial planning & analysis at Apple Computer.
Thépaut has driven innovation in high technology businesses throughout his career, leading organizational transformation initiatives and development programs as well as creating new selling models.
Eric earned his MBA at Paris Dauphine University.